Molecular Imaging in the Aid of Drug Delivery Technology
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, Yong Woo | - |
dc.contributor.author | Kim, Kwangmyeung | - |
dc.contributor.author | Park, Kinam | - |
dc.contributor.author | Kwon, Ick Chan | - |
dc.date.accessioned | 2021-06-23T00:44:12Z | - |
dc.date.available | 2021-06-23T00:44:12Z | - |
dc.date.created | 2021-01-22 | - |
dc.date.issued | 2014-09 | - |
dc.identifier.issn | 1598-5032 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/24601 | - |
dc.description.abstract | Molecular imaging aims to visualize biological processes in a living system at a molecular or cellularlevel while drug delivery systems (DDS) aim to deliver drugs to specific targets of tissues or organs at a controlledrate. Molecular imaging and DDS, seemingly two different subjects, however, are not completely separate. Theyshare overlapped conceptual and technological spectra. To visualize molecular events in body molecular imaging requiresdelivery of imaging probes to specific targets, which has been the main technology developed in DDS fordecades. Simply replacing drugs in targeted therapeutic DDS with imaging probes turns the whole system totargeted imaging system for diagnosis of diseases. Integrating imaging probes into therapeutic DDS is a startingpoint for theragnotics, therapy, and diagnosis performed simultaneously with one agent. Key DDS technologiesapplied to molecular imaging have played an important role in advances of molecular imaging. We here brieflydiscuss molecular imaging in the aid of drug delivery technology, with an emphasis on theragnotics of tumors. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 한국고분자학회 | - |
dc.title | Molecular Imaging in the Aid of Drug Delivery Technology | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Cho, Yong Woo | - |
dc.identifier.doi | 10.1007/s13233-014-2127-5 | - |
dc.identifier.scopusid | 2-s2.0-84918767503 | - |
dc.identifier.wosid | 000342414100002 | - |
dc.identifier.bibliographicCitation | Macromolecular Research, v.22, no.9, pp.926 - 931 | - |
dc.relation.isPartOf | Macromolecular Research | - |
dc.citation.title | Macromolecular Research | - |
dc.citation.volume | 22 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 926 | - |
dc.citation.endPage | 931 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001913963 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Polymer Science | - |
dc.relation.journalWebOfScienceCategory | Polymer Science | - |
dc.subject.keywordPlus | CHITOSAN NANOPARTICLES | - |
dc.subject.keywordPlus | COPOLYMERS | - |
dc.subject.keywordPlus | N-(2-HYDROXYPROPYL)METHACRYLAMIDE | - |
dc.subject.keywordPlus | VASCULATURE | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | PEPTIDE | - |
dc.subject.keywordAuthor | molecular imaging | - |
dc.subject.keywordAuthor | drug delivery system | - |
dc.subject.keywordAuthor | theragnostics | - |
dc.subject.keywordAuthor | tumor | - |
dc.subject.keywordAuthor | nanomedicine. | - |
dc.identifier.url | https://link.springer.com/article/10.1007%2Fs13233-014-2127-5 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.